Low Frequency Variants in the Exons Only Encoding Isoform A of HNF1A Do Not Contribute to Susceptibility to Type 2 Diabetes

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Jafar Mohammadi, Bahram ^a,b   Groves, Christopher J ^a   Owen, Katharine R ^a,b   Frayling, Timothy M ^c   Hattersley, Andrew T ^c   McCarthy, Mark I ^a,b,d   Gloyn, Anna L ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HNF1A PROTEIN, HUMAN;

ADULT; ARTICLE; EXON; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION;

ADULT; DIABETES MELLITUS, TYPE 2; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION;

EID: 74249120709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006615     Document Type: Article

References (24)

1. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, et al.(2001) beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 (Suppl 1): S94-100.
2. Bach I, Yaniv M, (1993) More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. Embo J 12: 4229-4242.
3. Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT, (2006) Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 15: 2216-2224.
4. Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, et al.(2005) Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54: 3126-3132.
5. Lango H, Palmer CN, Morris AD, Zeggini E, Hattersley AT, et al.(2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes.
6. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al.(2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9: 356-369.
7. Hugot JP, (2006) CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci 1072: 9-18.
8. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, et al.(2002) HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A 99: 4614-4619.
9. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B, (1999) The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84: 1077-1082.
10. Winckler W, Burtt NP, Holmkvist J, Cervin C, de Bakker PI, et al.(2005) Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes. Diabetes 54: 2336-2342.
11. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, et al.(2007) Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56: 685-693.
12. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, et al.(2005) A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54: 2487-2491.
13. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, et al.(1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710.
14. Ellard S, Bellanne-Chantelot C, Hattersley AT, (2008) Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51: 546-553.
15. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, et al.(2001) A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69: 553-569.
16. Wellcome Trust Case Control Consortium(2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
17. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al.(2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341.
18. Ellard S, Shields B, Tysoe C, Treacy R, Yau S, et al.(2009) Semi-automated unidirectional sequence analysis for mutation detection in a clinical diagnostic setting. Genet Test Mol Biomarkers 13: 381-386.
19. Gauderman W, Morrison J, (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies,http://hydra.usc.edu/gxe.
20. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al.(2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645.
21. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al.(2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
22. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al.(2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
23. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al.(2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
24. Shendure J, Ji H, (2008) Next-generation DNA sequencing. Nat Biotechnol 26: 1135-1145.